Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Respirology (Carlton South. Print)

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1843.2006.00809.xPMID 16423272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

  2006cited by this paper
• Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

  2005cited by this paper
• Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.

  2000cited by this paper
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

  2000cited by this paper
• Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.

  2000cited by this paper
• Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

  2000cited by this paper
• Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera.

  1997cited by this paper
• Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.

  1996cited by this paper
• Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.

  1995cited by this paper
• Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.

  1995cited by this paper
• KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.

  1993cited by this paper
• Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis.

  1993cited by this paper
• Ontogeny of surfactant apoprotein D, SP-D, in the rat lung.

  1991cited by this paper
• Appearance of surfactant proteins, SP-A and SP-B, in developing rat lung and the effects of in vivo dexamethasone treatment.

  1991cited by this paper
• Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein.

  1990cited by this paper
• Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A.

  1988cited by this paper
• Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay.

  1985cited by this paper
• Monoclonal antibodies against human pulmonary surfactant apoproteins : specificity and application in immunoassay

  1985cited by this paper
• Modifications of a specific assay for hydroxyproline in urine.

  1967cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis

  2025cites this paper
• Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study.

  2024cites this paper
• Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study

  2024cites this paper
• Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality

  2023cites this paper
• Usefulness and performance evaluation of serum KL-6 and SP-A assays in healthy individuals and patients with interstitial lung disease.

  2023cites this paper
• Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias

  2022cites this paper
• Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis

  2022cites this paper
• Examination of Surfactant Protein D as a Biomarker for Evaluating Pulmonary Toxicity of Nanomaterials in Rat

  2021cites this paper
• Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study

  2021cites this paper
• Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis

  2021cites this paper
• Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan

  2020cites this paper
• A retrospective clinical research of relapsed organizing pneumonia

  2020cites this paper
• Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis

  2020cites this paper
• Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.

  2020cites this paper
• Biomarkers in Interstitial Lung Diseases

  2020cites this paper
• Serum surfactant protein A as a surrogate biomarker of a negative heart sign among patients with interstitial lung disease

  2020cites this paper
• Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study

  2020cites this paper
• Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis

  2019cites this paper
• Organizing pneumonia with elevated surfactant protein-D needs attention to the possibility of relapse

  2019influential citation
• Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.

  2019cites this paper
• Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia

  2018cites this paper
• Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis

  2018cites this paper
• Blood Tests for the Diagnosis and/or Management of DLI: What Are the Clinical Significances of KL-6, SP-A, SP-D, and DLST in DLI?

  2018cites this paper
• Biomarkers in idiopathic pulmonary fibrosis.

  2018cites this paper
• Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease

  2018cites this paper
• Increased peripheral blood TCD4+ counts and serum SP-D levels in patients with chronic paracoccidioidomycosis, during and after antifungal therapy

  2017cites this paper
• Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis.

  2017cites this paper
• Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone.

  2017cites this paper
• Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis

  2017cites this paper
• Significance of Combined Emphysema in Idiopathic Pulmonary Fibrosis and Serum Surfactant Protein-D as a Prognostic Factor

  2017cites this paper
• Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease

  2017cites this paper
• CALL FOR PAPERS Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis

  2016cites this paper
• Idiopathic Pulmonary Fibrosis: Epidemiology, Clinical Features, Prognosis, and Management

  2016cites this paper
• Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis

  2016cites this paper
• Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.

  2016cites this paper
• Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.

  2015cites this paper
• Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study

  2015cites this paper
• Etiopathogenic Role of Surfactant Protein D in the Clinical and Immunological Expression of Primary Sjögren Syndrome

  2015cites this paper
• The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.

  2015cites this paper
• Seasonal variation of serum KL-6 and SP-D levels in bird-related hypersensitivity pneumonitis.

  2015cites this paper
• Elevation of serum surfactant protein-A with exacerbation in canine eosinophilic pneumonia

  2015cites this paper
• Factors Influencing the Measurement of Plasma/Serum Surfactant Protein D Levels by ELISA

  2014cites this paper
• Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms

  2014cites this paper
• Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis

  2014cites this paper
• Clinical value of surfactant protein-A in serum and sputum for pulmonary tuberculosis diagnosis.

  2013cites this paper
• Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

  2013cites this paper
• Serum surfactant protein D is associated with the prognosis in patients with chronic kidney disease

  2013cites this paper
• Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

  2013cites this paper
• Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.

  2013cites this paper
• Surfactant protein-A concentration in sera from dogs with pulmonary parenchymal diseases.

  2013cites this paper
• An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

  2013cites this paper
• Protective effects of neferine on amiodarone-induced pulmonary fibrosis in mice.

  2013cites this paper
• Pulmonary Collectins in Diagnosis and Prevention of Lung Diseases

  2012influential citation
• The Diagnosing and Staging of Idiopathic Pulmonary Fibrosis

  2012cites this paper
• Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias

  2011cites this paper
• Idiopathic Pulmonary Fibrosis

  2011cites this paper
• Significance of Serum Vascular Endothelial Growth Factor Level in Patients with Idiopathic Pulmonary Fibrosis

  2010cites this paper
• A Normal Range of KL-6/MUC1 Independent of Elevated SP-D Indicates a Better Prognosis in the Patients with Honeycombing on High-Resolution Computed Tomography

  2010cites this paper
• Nous factors inflamatoris de la diabetis tipus 2: SP-D, SP-A, a-Defensives i visfatina

  2009cites this paper
• The diagnosis of idiopathic pulmonary fibrosis and its complications.

  2008cites this paper
• The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.

  2008cites this paper
• The Effects of Fluticasone With or Without Salmeterol On Systemic Biomarkers of Inflammation in COPD

  2008cites this paper
• Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking

  2008cites this paper
• A Blood Test for Lung Fibrosis

  2008cites this paper
• Surfactant protein A and surfactant protein D variation in pulmonary disease.

  2007cites this paper
• Idiopathic pulmonary fibrosis

  2007cites this paper
• [Diffuse lung diseases and biological markers in serum].

  2006cites this paper
• Usual Interstitial Pneumonia

  2006cites this paper